By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cytokinetics, Inc. 

280 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-624-3000 Fax: 650-624-3010


Drug Discovery

Company News
Despite Conflicting Data, Cytokinetics, Inc. (CYTK) Plans To Take ALS Drug Into Late Stage Study 10/20/2014 11:21:03 AM
Cytokinetics, Inc. (CYTK) Announces Development Program Update For CK-2127107 10/13/2014 10:15:41 AM
Cytokinetics, Inc. (CYTK) To Present At The 34th Annual Canaccord Global Growth Conference 8/7/2014 2:03:46 PM
Cytokinetics, Inc. (CYTK) Announces Additional Data From BENEFIT-ALS To Be Presented At The 13th International Congress On Neuromuscular Diseases 7/3/2014 9:09:47 AM
Cytokinetics, Inc. (CYTK) Announces Data Relating To Tirasemtiv Presented At The 2014 Annual Spinal Muscular Atrophy Conference 6/16/2014 8:23:03 AM
Cytokinetics, Inc. (CYTK) Announces Further Results From BENEFIT-ALS Relating To Effects Following Withdrawal Of Tirasemtiv 6/2/2014 1:41:55 PM
Cytokinetics, Inc. (CYTK) To Hold Annual Meeting Of Stockholders 5/16/2014 12:08:35 PM
Bay Area's Cytokinetics, Inc. (CYTK) Plummets As ALS Drug Fails Phase 2B Study; Stock Down -64.67% At Market Close (April 25, 2014) 4/25/2014 6:42:00 AM
Amgen (AMGN), Cytokinetics, Inc. (CYTK) Heart Failure Drug Misses Phase 2 Goals; CYTK Stock Plummets -27.13% at Market Close (September 3, 2013) 9/3/2013 8:08:38 AM
Cytokinetics, Inc. (CYTK) Amends ALS Therapy Trial Design After Mistake 7/23/2013 7:32:35 AM